Epidemiology and clonality of multidrug-resistant Acinetobacter baumannii from a healthcare region in Hong Kong

Summary We assessed the risk factors and molecular epidemiology of multidrug-resistant Acinetobacter baumannii (MDR-AB) in Hong Kong. The patients were treated in five hospitals in a healthcare region during 2005–2006. We performed genomic identification by amplified rRNA gene restriction analysis (ARDRA) and investigated the existence of metallo-β-lactamases and the clonality of representative MDR-AB strains by phenotypic and molecular methods. Forty-five subjects with MDR-AB were compared with 135 controls (patients with no MDR-AB). In the logistic regression, chronic wound (odds ratio: 29.5, 95% confidence interval: 8.1–107.2; P adeB type XII, positivity for bla OxA-23-like and bla OxA-51-like genes and high level resistance to carbapenems. Most HKU1 strains retained susceptibility to gentamicin, cotrimoxazole and minocycline. By contrast, HKU2 strains exhibited ST22, adeB type II, and were usually positive only for the bla OxA-51-like gene and resistant to gentamicin, cotrimoxazole and minocycline. Both clones were found to have disseminated widely. In conclusion, clonal expansion is playing major roles in the increase of MDR-AB in these hospitals in Hong Kong. The findings highlight the need to enhance infection control measures.